Goldenwell Biotech annual net debt
2020
2021
2022
2023
2024
2025
Goldenwell Biotech Net Debt Growth & History (GWLL)
Goldenwell Biotech's net debt was −$26,775 for fiscal 2025.
View full Goldenwell Biotech company overviewGoldenwell Biotech annual net debt history
| Fiscal year | Period ended | Net debt | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | −$26,775 | −$151,356 | — |
| 2024 | 2024-12-31 | $124,581 | $131,477 | — |
| 2023 | 2023-12-31 | −$6,896 | $13,728 | — |
| 2022 | 2022-12-31 | −$20,624 | $145,153 | — |
| 2021 | 2021-12-31 | −$165,777 | $82,792 | — |
| 2020 | 2020-12-31 | −$248,569 | — | — |
Goldenwell Biotech quarterly net debt
Q4.20
Q1.21
Q2.21
Q3.21
Q4.21
Q1.22
Q2.22
Q3.22
Q4.22
Q1.23
Q2.23
Q3.23
Q4.23
Q1.24
Q2.24
Q3.24
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Net debt | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | −$11,143 | −$30,224 | — |
| Q1 2026 | 2026-03-31 | −$13,414 | −$172,372 | — |
| Q4 2025 | 2025-12-31 | −$26,775 | −$151,356 | — |
| Q3 2025 | 2025-09-30 | $49,966 | $54,721 | — |
| Q2 2025 | 2025-06-30 | $19,081 | $44,801 | — |
| Q1 2025 | 2025-03-31 | $158,958 | $183,179 | — |
| Q4 2024 | 2024-12-31 | $124,581 | $131,477 | — |
| Q3 2024 | 2024-09-30 | −$4,755 | $7,165 | — |
| Q2 2024 | 2024-06-30 | −$25,720 | −$8,590 | — |
| Q1 2024 | 2024-03-31 | −$24,221 | $19,854 | — |
| Q4 2023 | 2023-12-31 | −$6,896 | $13,728 | — |
| Q3 2023 | 2023-09-30 | −$11,920 | $17,040 | — |
| Q2 2023 | 2023-06-30 | −$17,130 | −$7,132 | — |
| Q1 2023 | 2023-03-31 | −$44,075 | −$16,526 | — |
| Q4 2022 | 2022-12-31 | −$20,624 | $145,153 | — |
| Q3 2022 | 2022-09-30 | −$28,960 | $152,500 | — |
| Q2 2022 | 2022-06-30 | −$9,998 | $178,396 | — |
| Q1 2022 | 2022-03-31 | −$27,549 | $158,434 | — |
| Q4 2021 | 2021-12-31 | −$165,777 | $82,792 | — |
| Q3 2021 | 2021-09-30 | −$181,460 | — | — |
| Q2 2021 | 2021-06-30 | −$188,394 | — | — |
| Q1 2021 | 2021-03-31 | −$185,983 | — | — |
| Q4 2020 | 2020-12-31 | −$248,569 | — | — |
Goldenwell Biotech net debt trends
Over the last five fiscal years, Goldenwell Biotech's net debt increased from −$248,569 to −$26,775, a change of $221,794. The latest reported quarter, Q2 2026, shows −$11,143.
About the metric
What net debt means
Net debt compares a company’s interest-bearing debt with its cash and cash equivalents. Positive net debt means debt exceeds cash, while a negative value indicates the company has more cash than debt on this measure.
Calculation and source
How net debt is calculated
TickerStat calculates net debt as total interest-bearing debt minus cash and cash equivalents at the same reporting-period end. Short-term investments are not subtracted because they are not included in the standardized cash series. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Goldenwell Biotech source filings ↗